Market Place
Sourcing Support
Atea To Present Bemnifosbuvir + Ruzasvir Data For Hepatitis C
07 Oct 2025 //
GLOBENEWSWIRE
Atea Presents Full Phase 2 Data on Hep C Combo at EASL 2025
07 May 2025 //
GLOBENEWSWIRE
Atea Pharmaceuticals to Present Best-in-Class Hepatitis C Regimen
23 Apr 2025 //
GLOBENEWSWIRE
Atea Pharmaceuticals Starts Phase 3 Study on Hepatitis C Virus
09 Apr 2025 //
GLOBENEWSWIRE
Atea Pharma Announces Positive Ph 2 Results for HCV Regimen
04 Dec 2024 //
GLOBENEWSWIRE
Larimar Therapeutics Reports Q3 2024 Finacial Results
30 Oct 2024 //
GLOBENEWSWIRE
Atea Pharma Presents Promising Bemnifosbuvir and Ruzasvir Combination Data
13 Nov 2023 //
GLOBENEWSWIRE
Atea to Present Bemnifosbuvir and Ruzasvir Data for Hepatitis C Virus
02 Nov 2023 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.